Literature DB >> 7895170

Effect of TAP on the generation and intracellular trafficking of peptide-receptive major histocompatibility complex class I molecules.

P M Day1, F Esquivel, J Lukszo, J R Bennink, J W Yewdell.   

Abstract

Using a fluorescein-conjugated antigenic peptide, peptide-receptive H-2Kb MHC class I molecules were found throughout the secretory pathways of RMA cells and peptide transporter (TAP)-deficient derivative cells (RMA/S). RMA/S cells displayed higher levels of intracellular peptide-receptive molecules, while, surprisingly, RMA cells expressed 3- to 5-fold more cell surface peptide-receptive molecules. Metabolic radiolabeling of Kb-associated oligosaccharides with [1-3H]galactose demonstrated that despite a large difference in the fraction of Kb molecules in native conformation in detergent extracts, Kb transport rates from the trans-Golgi complex to the surfaces of RMA and RMA/S cells were similar. Thus, although considerable numbers of class I alpha chains reach the RMA/S cell surface, they are a less productive source of peptide-receptive molecules than class I molecules synthesized by TAP-expressing RMA cells, suggesting paradoxically that TAP functions to increase the amount of peptide-receptive molecules at the cell surface.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7895170     DOI: 10.1016/s1074-7613(95)80014-x

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  28 in total

1.  Heat-aggregated noninfectious influenza virus induces a more balanced CD8(+)-T-lymphocyte immunodominance hierarchy than infectious virus.

Authors:  Yunjung Cho; Sameh Basta; Weisan Chen; Jack R Bennink; Jonathan W Yewdell
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

2.  A proteasome-dependent, TAP-independent pathway for cross-presentation of phagocytosed antigen.

Authors:  Nawel Merzougui; Roland Kratzer; Loredana Saveanu; Peter van Endert
Journal:  EMBO Rep       Date:  2011-12-01       Impact factor: 8.807

Review 3.  Class I MHC presentation of exogenous antigens.

Authors:  C V Harding
Journal:  J Clin Immunol       Date:  1996-03       Impact factor: 8.317

4.  Generation of CD8+ T cells specific for transporter associated with antigen processing deficient cells.

Authors:  E Z Wolpert; M Petersson; B J Chambers; J K Sandberg; R Kiessling; H G Ljunggren; K Kärre
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

5.  Sampling of major histocompatibility complex class I-associated peptidome suggests relatively looser global association of HLA-B*5101 with peptides.

Authors:  Daniel Gebreselassie; Hans Spiegel; Stanislav Vukmanovic
Journal:  Hum Immunol       Date:  2006-09-20       Impact factor: 2.850

6.  An in vitro study of the dynamic features of the major histocompatibility complex class I complex relevant to its role as a versatile peptide-receptive molecule.

Authors:  H Hörig; N J Papadopoulos; Z Vegh; E Palmieri; R H Angeletti; S G Nathenson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

7.  Direct delivery of exogenous MHC class I molecule-binding oligopeptides to the endoplasmic reticulum of viable cells.

Authors:  P M Day; J W Yewdell; A Porgador; R N Germain; J R Bennink
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

Review 8.  Cross-presentation by dendritic cells.

Authors:  Olivier P Joffre; Elodie Segura; Ariel Savina; Sebastian Amigorena
Journal:  Nat Rev Immunol       Date:  2012-07-13       Impact factor: 53.106

Review 9.  Designing CD8+ T cell vaccines: it's not rocket science (yet).

Authors:  Jonathan W Yewdell
Journal:  Curr Opin Immunol       Date:  2010-05-04       Impact factor: 7.486

10.  Cutting edge: MHC class I-Ly49 interaction regulates neuronal function.

Authors:  Ofer Zohar; Yoram Reiter; Jack R Bennink; Avital Lev; Sebastiano Cavallaro; Sabrina Paratore; Chaim G Pick; Gary Brooker; Jonathan W Yewdell
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.